BiotechTube

Tetanus-diphtheria-acellular pertussis (Tdap) vaccine

ApprovedCompleted
0 watching 0 views this week🔥 Hot
84
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Tetanus

Conditions

Tetanus, Diphtheria, Pertussis

Trial Timeline

Aug 1, 2006 → Oct 1, 2008

NCT ID
NCT00347958

About Tetanus-diphtheria-acellular pertussis (Tdap) vaccine

Tetanus-diphtheria-acellular pertussis (Tdap) vaccine is a approved stage product being developed by Sanofi for Tetanus. The current trial status is completed. This product is registered under clinical trial identifier NCT00347958. Target conditions include Tetanus, Diphtheria, Pertussis.

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00347958ApprovedCompleted

Competing Products

10 competing products in Tetanus

See all competitors
ProductCompanyStageHype Score
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®) + Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (BOOSTRIX®)SanofiApproved
84
Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus + Diphtheria and Tetanus Toxoids and Acellular Pertussis + Poliovirus + MMR + Varicella Virus + Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus + Diphtheria and Tetanus Toxoids and Acellular Pertussis + Poliovirus + MMR + Varicella VirusSanofiPhase 3
76
Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed + Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis AdsorbedSanofiApproved
84
DTaP-IPV/Hib Combined vaccine + DTaP-IPV vaccine and Hib vaccine + DTaP-IPV/Hib Combined vaccineSanofiPhase 3
76
Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed + Diphtheria and Tetanus toxoids adsorbedSanofiPhase 3
76
Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine + Tetanus and Diphtheria Toxoids Adsorbed For Adult UseSanofiApproved
84
Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis) + DTaP (Diphtheria & Tetanus Toxoids & Acellular Pertussis Adsorbed)SanofiPhase 3
76
Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1 + Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 2 + Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 3 + Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 4 + Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed + Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis VaccineSanofiPhase 1/2
40
Investigational Tdap vaccine Formulation B + Investigational Tdap vaccine Formulation C + Investigational Tdap vaccine Formulation A + Investigational Tdap vaccine Formulation D + Licensed Tdap vaccineSanofiPhase 1
32
Tetanus Immune Globulin (Human) + Diphtheria-Tetanus Toxoids AdsorbedGrifolsApproved
82

Other Products from Sanofi

Adacel®Approved
84
LACTIC ACID(ND)Approved
84
DupilumabApproved
84
glatiramer acetateApproved
84
INSULIN GLULISINE + INSULIN GLARGINEApproved
84